Principal Investigator
Lazaros Lekakis
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231175
Clinical Trial Summary
LONG-TERM FOLLOW-UP OF PATIENTS PREVIOUSLY TREATED WITH AUTOLOGOUS T CELLS GENETICALLY MODIFIED WITH VIRAL VECTORS
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Transplant/cellular therapy
Contact Information
Phone Number
305-243-2647